Injection Therapy for Stress Urinary Incontinence: A Review of Bulking Agents
Keywords:
Stress Urinary Incontinence (SUI), Periurethral Injections Bulking, Agents, Polyacrylamide Gel, Polyacrylamide GelTreatment, Efficacy and Safety, Recurrence RatesAbstract
Stress urinary incontinence (SUI) remains a significant medical and social issue, affecting millions of women worldwide. The literature identifies SUI as a prevalent condition, particularly among women aged 30-65, with risk factors including childbirth, pelvic surgery, and menopause. Despite the availability of numerous treatments, periurethral injections using bulking agents have gained attention for their minimally invasive nature. However, limited comprehensive data is comparing their long-term efficacy and safety.
This review examines the etiopathogenesis, diagnosis, and treatment options for SUI, focusing on periurethral injections. A systematic review of Russian and international sources was conducted, analyzing the effectiveness of various bulking agents such as autologous fat, silicone, and hyaluronic acid derivatives. Findings indicate that while periurethral injections offer a promising alternative to traditional surgical methods, their success is contingent on the choice of material, with efficacy rates varying from 45% to 90%. Moreover, complications such as urinary retention, infection, and potential migration of the material were noted.
The study underscores the need for further research to identify optimal materials that balance long-term efficacy with minimal side effects. The findings have significant implications for improving treatment protocols and patient outcomes in managing SUI.
References
Шахалиев, Р. А., Шульгин, А. С., Кубин, Н. Д., Кузьмина, И. Н., Сучков, Д. А., & Шкарупа, Д. Д. (2022). Современное состояние проблемы применения трансвагинальных сетчатых имплантов в хирургическом лечении стрессового недержания мочи и пролапса тазовых органов. Гинекология, 24(3), 174-180.
Кира, К. Е., Безменко, А. А., & Кира, Е. Ф. (2010). Слинговые операции в лечении стрессового недержания мочи у женщин. Вестник Национального медико-хирургического центра им. НИ Пирогова, 5(4), 126-132.
Ермакова, Е. И. (2018). Инъекционный метод лечения стрессового недержания мочи (обзор литературы). Гинекология, 20(6), 31-34.
Русина, Е. И., & Жевлакова, М. М. (2021). Объемообразующие вещества при малоинвазивной коррекции стрессового недержания мочи у женщин. Журнал акушерства и женских болезней, 70(4), 115-124.
Курбанов, Б. Б. (2018). Современная хирургическая тактика лечения пролапса гениталий и стрессового недержания мочи. РМЖ. Мать и дитя, 1(1), 44-48.
АПОЛИХИНА, И. А., Саидова, А. С., & Махмеджанова, Ф. Н. (2011). Применение объемообразующих средств для лечения стрессового недержания мочи у женщин. Акушерство и гинекология, (7-1), 21-24.
Muzafarovna, M. M. (2024). Comparative Analysis of PRP and TVT-O in Urinary Incontinence Surgery. International Journal of Integrative and Modern Medicine, 2(8), 33-35.
Nikolopoulos, K. I., Pergialiotis, V., Perrea, D., & Doumouchtsis, S. K. (2016). Restoration of the pubourethral ligament with platelet rich plasma for the treatment of stress urinary incontinence. Medical hypotheses, 90, 29-31.
Kavia, R., Rashid, T. G., & Ockrim, J. L. (2013). Stress urinary incontinence. Journal of Clinical Urology, 6(6), 377-390.
Kavia, R., Rashid, T. G., & Ockrim, J. L. (2013). Stress urinary incontinence. Journal of Clinical Urology, 6(6), 377-390.
